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Abstract
To study the effect of leukemia inhibitory factor (LIF) on rat retinal vascular development, Sprague–
Dawley rats at postnatal age 3 days (p3) were given intraperitoneal (IP) LIF and analysis performed
at p6 (p3/6). p7 rats were given intravitreous (IV) LIF and analysis performed at p9 (p7/9). Control
animals were PBS injected. At the time of analysis retinal flatmounts were prepared and stained with
Griffonia lectin and activated caspase-3. The retinal peripheral avascular area was measured and
number of apoptotic cells counted. In vitro, human retinal microvascular endothelial cells (RMVECs)
were cultured in media containing LIF, with and without neutralizing antibody to LIF. Cells were
stained with activated caspase-3 and apoptotic cells counted. Proliferation was measured by counting
cell numbers, and cell cycle stage was determined using propidium iodide staining and FACS
analysis. LIF injected either IP or IV had no effect on body weight or total retina area, but significantly
increased the peripheral retinal avascular area. In both IP and IV injected groups there was no
difference in the number of apoptotic cells between PBS-or LIF-injected groups; although in the p7/9
retinas, both injected groups had significantly more apoptotic cells than the non-injected group. In
vitro, there was no effect of LIF on RMVEC apoptosis; however, cell counts were significantly lower
in the LIF-treated group. Antibody to LIF restored the cell counts to untreated levels. LIF reduced
the number of cells in S phase. LIF attenuates retinal vascular development in vivo through growth
arrest, and not apoptosis, of endothelial cells.
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1. Introduction
Leukemia inhibitory factor (LIF) is a multifunctional, pleiotrophic cytokine (Metcalf, 2003)
best known for its ability to maintain stem cell pluripotency in vitro (Williams et al., 1988).
Although not normally expressed in adult tissue, LIF has a central role in human fertility
(Senturk and Arici, 1998), especially during uterine blastocyst implantation (Stewart et al.,
2003). It can be induced by ischemia-reperfusion injury in cortical neurons and neighboring
astrocytes (Suzuki et al., 2000) and has been reported as a survival factor for neurons, astrocytes
(Gadient et al., 1998), and oligodendrocytes (Butzkueven et al., 2002).
LIF is a member of the interleukin-6 family of cytokines (Heinrich et al., 2003). All members
have their own specific receptors, but share the common feature of binding to the
transmembrane receptor subunit, glycoprotein 130 (gp130) (Yamauchi-Takihara, 2002). LIF
binding to its receptor LIFR causes tyrosine phosphorylation and formation of a heterodimer
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with gp130. This binding induces activation and signaling through Janus kinase/signal
transducers and activators of transcription (JAK/STAT) pathways (Auernhammer and
Melmed, 2000).
The effect of LIF on angiogenesis is contradictory. It has been shown to cause proliferation
(Gendron et al., 1996) and induce tube-formation (Paradis and Gendron, 2000) of an embryonic
endothelial cell line. However, it had differential effects on bovine endothelial cells depending
on the tissue origin of the cells. Growth (Ferrara et al., 1992), migration, and proliferation
(Pepper et al., 1995) of aortic endothelial cells were strongly inhibited by LIF, whereas these
properties were unaffected in adrenal cortex-derived capillary endothelial cells (Ferrara et al.,
1992). LIF’s anti-angiogenic properties have been partly attributed to its ability to modulate
integrin subunit expression (Collo and Pepper, 1999). LIF has also been demonstrated to arrest
an epithelial tumor cell line in the G0/G1 phase (Park et al., 2003) and prevent entry of a murine
pituitary cell line into S-phase (Stefana et al., 1996), although these effects have not been
demonstrated in any type of endothelial cell.
Overexpression of LIF in the lens of transgenic mice resulted in a reduced hyaloid vasculature
at birth and no retinal vasculature in the first 2 weeks postnatal (Ash et al., 2005). It was also
shown to disrupt retinal neuronal development (Sherry et al., 2005) resulting in less cells and
a loss of the normal structure. In culture, Muller-cell derived LIF was shown to arrest rod
photoreceptor differentiation (Neophytou et al., 1997) and increase RPE survival (Gupta et al.,
1997). Because LIF is inducible in adults and has been shown to be produced in retinal cells,
we were interested in the effect of LIF on the development of the retinal vasculature. This may
have implications for understanding LIF’s possible role in disease.
2. Methods
2.1. In vivo assays: animals
Sprague–Dawley rats (Charles River, MA) were treated in accordance with the ARVO
statement for the Use of Animals in Ophthalmic and Vision Research.
2.2. Staining of retinal tissue for flatmounting
Rat pups were anesthetized by IP injection of ketamine (2.5 mg/kg) and xylazine (1 mg/kg).
Paraformaldehyde (PFA) was then directly perfused (0.4 ml 0.5%) into the left ventricle, prior
to euthanasia by intracardiac injection of 80 mg/kg Nembutol (NLS Animal Health, MD). Both
eyes were enucleated, and whole eyes were fixed in 2% PFA for 2 h before being washed in 1
M PBS pH 7.4. The retinas were dissected using a modification of the method of Chan-Ling
(1997). Briefly, under a dissecting microscope, an incision was made at the limbus, and the
cornea was circumcised from the sclera. The lens was gently removed without disturbing the
retina. The remaining eyecup was transferred to PBS, and the full extent of the retina with the
ora serrata intact was eased from the sclera using fine forceps. The retina was then placed onto
a microscope slide and flattened by making four incisions, each 90 degrees apart, beginning
at the ora serrata and extending centrally from the equator stopping short of the optic nerve
opening. As much vitreous as possible was removed using cellulose sponges and scissors.
2.3. Apoptosis staining
Flattened retinas were washed in 1 M PBS for 10 min, followed by pre-blocking in 1 M PBS
with 3% bovine serum albumin (BSA, Sigma) for 30 min at room temperature. Primary
activated caspase-3 antibody directly conjugated to FITC (Cell Signaling Technology, MA)
was diluted 1:100 in PBS (3% BSA) and added to the slides that were incubated overnight at
4 °C. The retinas were washed three times in 1 M PBS for 5 min each. The retinas were then
incubated overnight at 4 °C in TRITC conjugated Griffonia simplicifolia lectin (GSL, Sigma,
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MN) diluted to 20 μg/ml. Slides were washed three times in 1 M PBS for 10 min each. For
nuclear staining, the retinas were covered for 30 min with Hoechst (Molecular Probes, OR)
diluted 1:5000 in 1 M PBS. Slides were washed three times in PBS for 30 min, mounted in
PBS:glycerol (1:2), and viewed using a confocal microscope.
2.4. Analysis of apoptotic cells
The blood vessels of the retina were viewed using a Leica SP2 laser confocal microscope.
Three images were captured within each of the four retinal quadrants: one at the peripheral
edge of the vasculature near the ora serrata, one close to the optic nerve head, and one
equidistant between these two. Images were taken so as to avoid the major vessels. Within
these areas all cells that were caspase-3 positive were counted. The sum of the 12 areas gave
a total cell count in 1.7 mm2.
2.5. Analysis of avascular areas
For total retinal areas, images were captured using a Nikon TE2000U microscope with a 2×
lens. Four images were captured to cover the total retinal area, and the images were montaged
in Adobe Photoshop to give a single image of the retina. The total retinal area and peripheral
avascular area in these images were measured using the freeware ImageTool (Version 3.0,
University of Texas, TX), and the avascular area was expressed as a percentage of the total
retinal area.
2.6. Tissue preparation for RT-PCR
Animals were euthanized with an overdose of pentobarbital (0.2 mg/ml IP). Brain tissue was
removed using forceps, placed immediately into RNAlater (Ambion, CA), and frozen at − 20
°C until analysis. Both eyes were enucleated and the retinas were dissected under a dissecting
microscope as described in the method for flatmounting retinas. However, the ora serrata was
removed by gently pulling or cutting away from the retina before it was placed in RNAlater
and frozen at − 20 °C until analysis.
2.7. Semi-quantitative RT-PCR
Samples were removed from RNAlater, and RNA extracted using Absolutely RNA Miniprep
Kit (Stratagene, CA). DNA contamination was removed by using DNA-free (Ambion, TX),
and RNA quantity was determined spectrophotometrically. Reverse transcription was done
using Retroscript Kit (Ambion, TX). Briefly, 1 μg of RNA and 2 μl of random decamers were
made up to a volume of 12 μl in nuclease free water. This was mixed, spun briefly, and heated
at 75 °C for 3 min. To it, 2 μl 10× RT buffer (500 mM Tris–HCl, pH 8.3, 750 mM KCl, 30
mM MgCl2, and 50 mM DTT), 4 μl dNTP (2.5 mM each), 10 U RNase inhibitor, and 100 U
MMLV-reverse transcriptase were added. The RT reactions were incubated at 42 °C for 60
min and terminated at 92 °C for 10 min. Samples were frozen at this stage until PCR.
PCR was performed using specific primers to rat LIF (forward 5′-tgt gcc cct act gct cat tct g;
reverse atc cca ggt gat gtt ggt cag g-3′ annealing temperature 62 °C) or rat gp130 (forward 5′-
ctt ctc acc ccg tag tgg atc tta and reverse gac tat ggc ttc gat ttc tcc tt -3′ annealing temperature
58 °C). Products were LIF at 343 bp and gp130 at 599 bp.
The linear range of each sample was determined empirically by increasing the number of cycles
and resolving the products on a 2% agarose gel (USB Corporation, OH). Sample reactions
were 2.5 μl cDNA, 5 μl 10× PCR complete buffer (100 mM TriseHCl, pH 8.3, 500 mM KCl,
and 15 mM MgCl2), 2.5 μl dNTP mix (2.5 mM each), 1 μl primer mix (5 μM of each primer),
1 U superTaq polymerase (Ambion, TX).
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The control gene was 18S ribosomal RNA and was amplified using a QuantumRNA
primer:competimer set (Ambion, TX) yielding a band at 489 or 315 bp. Because the 18S is far
more abundant than most other RNA, 18S amplification was reduced by adding competimers
which compete with 18S primer for binding. The competimers are primers modified at their 3′
ends to block extension by DNA polymerase.
The ratio of primer:competimer was quantified empirically by increasing the ratio at the
predetermined number of cycles (see above). 2.5 μl of cDNA was added to 5 μl 10× PCR
complete buffer (100 mM Tris–HCl, pH 8.3, 500 mM KCl, and 15 mM MgCl2), 2.5 μl dNTP
mix (2.5 mM each), 1 μl primer:competimer mix, 1 U superTaq polymerase (Ambion, TX).
Samples were resolved on a 2% agarose gel, and the 18S rRNA band that had an intensity equal
to that of the sample was selected for use in the relative-quantification.
For semi-quantitative analysis, a multiplex reaction with both specific primers and the 18S
primers in the same sample was performed. Triplicates of each sample were run on a 2% gel
and the bands were captured digitally using the UVP ChemiDoc System including a Chemi
cooled CCD camera, PCI digitizing image acquisition board, EpiChemi II Darkroom with
transilluminator, and LabWorks 4.0 Software. Data were exported to an Excel spreadsheet for
data calculation where values were expressed relative to 18S within each sample. All PCR
products were confirmed by gel extraction (Qiagen, CA) and sequence analysis (UNC Core
Facility, http://152.19.68.152/gafsite/main.asp).
2.8. LIF injections
Sprague–Dawley rat pups (Charles River, MA) at postnatal age 3 days were injected
intraperitoneally (IP) with 100 ng rat LIF (Chemicon, CA) in 0.1 ml sterile PBS. Controls were
injected IP with 0.1 ml sterile PBS. For older pups, intravitreous injections of LIF were given
at p7. These methods were chosen because p3 animals had exuberant wound healing responses
after intravitreous injections that affected retinal dissection and the results. All intravitreous
injections were done in the right eye with either LIF in PBS (5 ng/μL) or PBS. Controls were
non-injected left eyes. Analysis of avascular areas were performed as described above.
2.9. Immunoprecipitation and Western blotting for phosphorylated gp130
Freshly dissected retinas were lysed in 500 μL of modified RIPA lysis buffer (10 mM Tris–
HCl pH 7.4, 150 mM NaCl, 0.1% SDS, 1% sodium deoxycholate plus protease inhibitor
cocktail and sodium orthovanadate) in 1.5 mL centrifuge tubes, on ice for 20 min with frequent
mixing. Lysates were clarified by spinning at 13,000 rpm for 25 min at 4 °C and supernatants
were removed to new tubes. 10 μL from each sample were used to quantify protein by the
Bradford method using standard protocols. 1.5 μg of anti-gp130 rabbit polyclonal antibody
(Santa Cruz, CA) plus 30 μL of a 50% slurry of protein A-conjugated sepharose (Amersham,
NJ) were added to each equalized sample. These were incubated overnight at 4 °C with
continuous rocking, then washed three times with lysis buffer. Finally, an equal volume of
sample buffer was added to the sepharose beads after the final wash and the samples were run
on a 10% SDS-PAGE gel electrophoresis, followed by transfer to PVDF membranes. Western
blotting was performed using a phosphotyrosine specific monoclonal antibody (BD
Bioscience, CA), then anti-mouse HRP-conjugated secondary antibody (Jackson Laboratory),
followed by enhanced chemiluminescence (Pierce, IL).
Radiographic films were scanned using a Cannon 4200F scanner and Adobe Photoshop 7.0
software. Band intensities were analyzed by densitometric analysis with UN-Scan-it digitizing
software (Silken Scientific, Utah) and average ratios of phosphor-gp130 to total gp130 plus
standard deviations as well as data graphs were generated using Microsoft Excel. One-way
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analysis of variance (ANOVA) and Tukey–Kramer multiple comparisons post test were
preformed using Graph-Pad Instat 3.0.
2.10. In vitro assays: human retinal endothelial cells (RMVECs)
2.10.1. Effect of exogenous LIF on proliferation of RMVECs—Human retinal
microvascular endothelial cells (RMVECs, Cell Systems, WA cat #: ACBRI-181; kindly
provided by Gerard Lutty PhD, Wilmer Eye Institute) were plated at 5000/cm2 in low glucose
DMEM (Invitrogen, CA) containing 120 μg/ml endothelial cell growth supplement (ECGS,
Sigma, MO), 100 μg/ml heparin (Sigma, MO) and 10% fetal bovine serum (FBS, Sigma, MO).
After 5 h, the media were removed and replaced with identical media except they contained
only 5% FBS and a serial dilution of hLIF at 5, 10, 25 and 50 ng/ml (Chemicon, CA). Controls
were cells cultured in 5% FBS medium without hLIF or 25 ng/ml hLIF plus 500 ng/ml
neutralizing LIF antibody (R & D Systems, MN). After 4 days the cells were trypsinized and
counted in a Z1 series Coulter Counter (Beckman-Coulter, CA). Results were expressed as
fold increase compared to control that contained no LIF.
2.10.2. RMVECs apoptosis cell staining—RMVECs were seeded at 1 × 105 cells/cm2
in a CC2 chamber slide 8-well system (Nunc, NY) in DMEM supplemented with 120 μg/ml
ECGS, 100 μg/ml heparin and 10% FBS. After 5 h, the media were removed and replaced with
identical media except they contained only 5% FBS. hLIF was added at 25 ng/ml with or
without LIF antibody at 500 ng/ml. Cells were grown for 2 days at 37 °C in 5% CO2. As a
positive control for apoptosis, cells grown for 2 days but without LIF or LIF antibody were
replaced with DMEM (supplemented with 5% FBS) containing 1 μg/ml staurosporine (Sigma,
MO) and incubated for 6 h at 37 °C in 5% CO2. All wells were then washed three times with
1 M PBS containing 0.5% Triton X-100 (Sigma, MO) and fixed for 15 min in 2%
paraformaldehyde (Sigma, MO) at room temperature. After three washes in 1 M PBS, the cells
were permeabilized in ice cold methanol for 10 min. The cells were washed and pre-blocked
in 1 M PBS containing 3% BSA (Sigma, MO) and Triton X-100 for 30 min. The cells were
then incubated overnight at 4 °C in FITC-conjugated activated caspase-3 antibody diluted
1:250 in 1 M PBS containing 3% BSA. The cells were washed three times and incubated at 37
°C in 25 μg/ml propidium iodide (Sigma, MO) for 30 min. The cells were washed three times
and mounted in PBS:glycerol (2:1) containing VectaShield (Vector Labs, CA). Images were
captured using a Leica SP2 scanning laser confocal microscope.
2.11. Exogenous LIF and the cell cycle of RMVECs
RMVECs were plated in 6-well plates at 13,000/cm2 in low glucose DMEM containing 120
μg/ml ECGS, 100 μg/ml heparin and 10% fetal bovine serum. After 5 h, the media were
removed and replaced with low glucose DMEM containing 5% FBS and 10 or 25 ng/ml of
hLIF. Controls had no LIF. The cells were grown for 24 h after which they were trypsinized
and spun at 200 × g for 5 min. The supernatant was removed and the cells stained with
propidium iodide. Briefly, cells were resuspended in 100 μl ice cold 70% ethanol for 30 min.
Cells were spun at 3000 × g for 5 min and resuspended in 1 ml of PBS with 2% FBS. Cells
were spun again at 3000 × g for 5 min and resuspended in 100 μg/ml RNase A (Sigma, MO)
in PBS and incubated at 37 °C for 30 min. Propidium iodide (20 μg/ml) was added and
incubated for 30 min at room temperature. Total DNA content was measured within 24 h using
a FACSCalibur Flow Cytometer (BD Biosciences, CA).
2.12. Statistics
Statistics were performed using SPSS for Windows v12.0 (Chicago, IL) or GraphPad Instat
v3.0.
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Experiments were performed at least in triplicate and results expressed as mean and standard
deviations. A t-test was used to analyze two groups. For more than two groups, analysis was
performed with an ANOVA. Post-hoc testing was done using the Bonferroni correction or
Student–Newman–Keuls multiple comparisons. Significance was reported at p < 0.05.
3. Results
3.1. LIF and gp130 mRNA in developing brain and retina
Expression of LIF and its receptor subunit gp130 in developing brain and retina was measured
at p2, 7, and 14. LIF mRNA expression was readily detectable in control brain tissue throughout
early development (Fig. 1A). Densitometry results of LIF, normalized to 18S, showed mean
values ± standard deviation (SD) at p2: 0.85 ± 0.11, p7: 0.84 ± 0.15, and p14: 0.41 ± 0.12. LIF
mRNA was undetectable in retina (results not shown).
gp130 mRNA was detectable in both brain (Fig. 1B) and retina (Fig. 1C) throughout
development. Densitometry results of gp130 normalized to 18S in brain samples had mean
values ± SD at p2: 2.09 ± 0.21; p7: 1.76 ± 0.56; and p14: 1.91 ± 0.44), suggesting that expression
early on remained relatively constant through development. In the retina, densitometry results
normalized to 18S showed mean values ± SD at p2: 2.39 ± 0.2, p7: 3.96 ± 0.24, and p14: 4.7
± 0.03) demonstrating that expression significantly increased in the developing retina (p <
0.005 overall ANOVA, with each value significantly different from each other at p < 0.003
Bonferroni correction).
3.2. LIF attenuates retinal vascularization in developing rat pups when injected both locally
and systemically
Previously, our group quantified rat retinal vascularization at time points during development
(McColm et al., 2004) and found similar results to other groups (Ishida et al., 2003). At p6, 3
days after IP injection there was no difference in total weights or total retinal area of PBS-
versus LIF-injected pups (Table 1). However, in LIF-injected animals, there was significantly
greater peripheral avascular retina compared to PBS-injected pups (mean percent avascular ±
SD, 39.7 ± 5.5% vs 36.8 ± 5.8% respectively, p < 0.045 t-test, Table 1 and Fig. 2).
Similar results were seen when LIF was injected directly into the vitreous. First, the non-
injected left eye from the PBS-injected group and the non-injected left eye from the LIF-
injected group were compared. There was no difference in body weight, total retinal area or
avascular peripheral area (results not shown). Therefore, all of these data were grouped together
into one group designated non-injected. There was no difference in total weight or total retinal
area in PBS-injected and LIF-injected animals. However, there was a significantly larger
peripheral retinal avascular area in LIF-injected (9.1 ± 4.4%) vs. PBS-injected (5.7 ± 3.3%) or
non-injected pup eyes (4.7 ± 3.8%) (Fig. 2 and Table 1, p < 0.0001 overall ANOVA, LIF-vs.
non-injected eyes p < 0.0001, LIF-vs. PBS-injected eyes p < 0.022, Bonferroni post-hoc
testing). There was no significant difference in the peripheral retinal avascular area between
non-injected and PBS-injected eyes. The numbers of animals in the PBS-and LIF-injected
groups were similar at the start of the experiment. However, when intravitreous injection
interfered with the ability to dissect complete retinal whole mounts necessary to analyze
avascular/total retina, these eyes were not included in the analysis. For this reason, the number
of samples for analysis differed among groups.
3.3. Intravitreous injection increases apoptosis in the inner capillary plexus, but IP injection
does not
During development of the inner retinal capillary plexus, we found apoptosis from p2 through
p10 (Fig. 3). This has been reported by others (Hughes and Chan-Ling, 2000) and is part of
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normal remodeling that occurs in the developing retinal vasculature. After p10, apoptosis was
significantly reduced (overall ANOVA p < 0.0005; p2 vs. p12 and p14, p < 0.001 Bonferroni;
Fig. 3).
Analysis of apoptotic staining of the retina revealed that IP injection did not significantly
increase apoptosis (mean cells counted/mm2 ± standard deviation, 9.7 ± 5.2 PBS-injected vs.
16.3 ± 7.9 LIF-injected, p = 0.08 t test). However, in the intravitreous-injected group there was
a significant increase in caspase-3 positive positive cells in both injected groups compared to
controls (PBS-vs non-injected p = 0.001, LIF-vs non-injected p = 0.0001, Fig. 4). There was
no significant difference in the apoptosis counts between PBS-injected and LIF-injected. It
was noted that caspase-3 positive cells when double stained with lectin, were within and not
part of the capillary. As Griffonia isolectin B4 can also bind to other cell types, including
microglia and leukocytes (Cho et al., 2002) it was unlikely these double stained lectin and
caspase-3 cells were endothelial cells.
3.4. Effect of exogenous LIF on proliferation and apoptosis of cultured endothelial cells
Cell proliferation, measured by cell counts, was significantly decreased in the presence of LIF
(p < 0.0001, overall ANOVA; Fig. 5). Addition of LIF antibody to media containing LIF
restored cell proliferation to control levels, and antibody to LIF alone had no significant effect
on cell proliferation (results not shown).
LIF and LIF plus antibody had no effect on apoptosis in cultured RMVECs compared to control
(Fig. 6B,C vs A respectively), whereas staurosporine caused apoptosis in 100% of cells (Fig.
6D, double stained yellow cells).
3.5. Injection of intraocular LIF caused increased phosphorylation of gp130
Phosphorylation of the gp130 receptor was significantly increased by LIF injection, while
uninjected and PBS injected eyes had similar results (Fig. 7).
3.6. Cell cycle analysis
For each sample histograms were generated of cell number vs total fluorescence and then cell
populations were assigned manually to a cell cycle stage according to quantity of total DNA.
Results of nine separate runs were averaged and showed that there was less cells in S phase in
the presence of LIF (Fig. 8, both concentrations p < 0.001 compared to controls).
4. Discussion
We found that exogenously administered LIF, given systemically or into the vitreous, caused
an arrest in retinal vascular development. LIF did not cause significant growth retardation
compared to the animals in the non-injected or PBS-injected groups. Both body weights and
total retinal areas were comparable amongst all experimental groups.
We provide evidence that the effect of LIF was through growth arrest rather than apoptosis of
endothelial cells. In vivo, there was no increase in the number of apoptotic cells in the IP-
injected LIF group compared to PBS-injected group, even though there was a significantly
larger peripheral avascular retinal area in the LIF-injected group. In p7 pups that had
intravitreous injections, there was a greater number of apoptotic cells in both PBS- and LIF-
injected groups compared to the non-injected group, but no difference between the two injected
groups. The LIF-injected group had a significantly larger peripheral avascular retinal area
compared to the PBS-injected group. This finding suggests that apoptosis was associated with
effects from the injection, but that the increased avascularity seen with LIF administration was
not mainly due to apoptosis or from the injection.
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In vitro studies using RMVECs support the in vivo data and provide additional evidence that
LIF does not increase apoptosis. When RMVECs were cultured in the presence of LIF, there
was a significant decrease in cell proliferation compared to cells grown without LIF. This effect
could be reversed when LIF antibody was added to cells exposed to LIF. LIF did not affect
RMVECs apoptosis, but did reduce proliferation and entry into S phase. The in vitro and in
vivo results provide evidence that LIF may prevent retinal vascularization through EC growth
arrest and not through EC apoptosis. This is in agreement with Ash et al. (2005) who
demonstrated that LIF overexpressed in the lens of mice resulted in absence of the retinal
vasculature, rather than regression of an existing vascular network.
Although LIF was not detected in the retinal tissue during normal development, it was readily
detectable in the brain. The receptor subunit, gp130, was also found in both brain and retina,
so if LIF had access to the retina, signaling through gp130 would be possible.
gp130 belongs to the LIF/IL-6 family of receptors that are expressed predominantly on
neuronal cells in the retina (Rhee and Yang, 2003), but also have been shown to be present in
endothelial cells (Modur et al., 1997). Ligands of the LIF/IL-6 family all have their own
receptors and form different heterodimers with gp130 (Yamauchi-Takihara, 2002). Ligands
that signal through these receptors have contradictory effects on angiogenesis. LIF induced an
embryonic cell line to proliferate and form capillary-like structures through STAT3 signaling
(Paradis and Gendron, 2000). However, bovine aortic endothelial cells were strongly inhibited
by LIF (Ferrara et al., 1992; Pepper et al., 1995) and adrenal cortex-derived capillary
endothelial cells were unaffected (Ferrara et al., 1992). IL-6 has been shown to stimulate
angiogenesis through STAT3-induced VEGF expression (Wei et al., 2003). One explanation
of the different effects on angiogenesis in this family of cytokines and receptors might be that
alternate signaling pathways are activated downstream of gp130.
We showed that systemically administered LIF produced a local effect on the developing retinal
vasculature. Therefore, it is conceivable that soluble LIF produced in other tissues either during
development (e.g. brain) or increased after ischemia-reperfusion (Ikegami et al., 2002; Suzuki
et al., 2000) could access the retina and affect retinal vascular development. Retinal Muller
cells in vitro have been stimulated to produce LIF (Neophytou et al., 1997); therefore, at least
some cells in the retina are capable of LIF expression under the correct conditions. Previous
studies in mice showed that LIF mRNA expression levels were very low, especially in postnatal
tissue (Murphy et al., 1993). Thus, LIF may be present in the developing retina but undetectable
by current methods.
Our data agrees with that of Ash et al. (2005) that showed that when overexpressed in mouse
lens, LIF resulted in reduced retinal vasculature. Other studies show that LIF can arrest
epithelial tumor cells in G0/G1 phase (Park et al., 2003). We now show that LIF can prevent
entry of endothelial cells into S phase and that exogenous LIF delivered both systemically and
locally attenuates retinal vascular development. These effects may have implications in certain
diseases that occur during retinal vascular development.
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(A) LIF mRNA and (B) gp130 mRNA during brain development and (C) gp130 during retina
development. Lane 1 postnatal age (p)2, lane 2 p7, and lane 3 p14.
McColm et al. Page 11














Retinal wholemounts stained with Griffonia lectin. Left side scale bar represents 1 mm; Right
side is a higher magnification image of the top quadrant from respective image on right with
scale bar representing 0.25 mm. p7 intravitreous injected rat pups analyzed at p9 (A and B,
non-injected; C and D, PBS-injected; E and F, LIF-injected). G and I, p3 intraperitoneal
injected rat pups analyzed at p6 (G and H, PBS-injected; I and J, LIF-injected).
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Total caspase-3 positive cells in the inner capillary layer during normal development. Overall
ANOVA significant at p < 0.001. *p12 is significantly different from p2, p7 and p10 (p <
0.0005, p = 0.003 and p = 0.031 respectively). **p14 was significantly different from p2 and
p7 (p = 0.001 and p = 0.006 respectively).
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Apoptotic cells counted in the inner capillary plexus of p9 animals given intravitreous injection
at p7. Overall ANOVA was significant at p < 0.0001. Post hoc testing with the Bonferroni
correction *p = 0.001, **p = 0.0001 compared to non-injected. There was no difference
between the PBS-and LIF-injected groups.
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Effect of exogenous LIF on RMVEC proliferation in vitro. Overall ANOVA (p < 0.001). All
p values in the figure represent the post-hoc Bonferroni test. ab, antibody; LIF, leukemia
inhibitory factor.
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Retinal microvascular endothelial cells grown with LIF and stained with antibody to activated
caspase-3 (green) and propidium iodide (red). (A) Controls without LIF. (B) LIF, (C) LIF plus
antibody. LIF and LIF plus antibody had no effect on apoptosis compared to control (B, C vs
A respectively). (D) RMVECs grown with staurosporine which caused apoptosis in all cells
(double stained yellow cells).
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(A) Western blot of phosphorylated and total gp130 in uninjected eyes (Un), PBS injected or
LIF injected. (B) Densitometry analysis of Western blot. Uninjected and PBS injected had
similar amounts of gp130 phosphorylation, whereas eyes injected with LIF showed an increase
in gp130 phosphorylation (overall ANOVA p = 0.0226, *p < 0.05 vs uninjected and PBS
injected).
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Cell cycle stages measured by flow cytometry analysis of total DNA staining by propidium
iodide (overall ANOVA p < 0.001; *p < 0.001 compared to control).
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Table 1
Summary statistics for animals injected at postnatal age 3 and analyzed at p6 (p3/6) and animals injected at p7
and analyzed at p9 (p7/9)





Intraperitoneal p3/6 PBS 28 33.0 ± 1.9 36.8 ± 5.8 11.4 ± 1.1d
LIF 37 33.6 ± 3.1 39.7 ± 5.5b 11.4 ± 0.8d
Intravitreous p7/9 Non-injecteda 49 38.8 ± 3.8 4.7 ± 3.8 –
PBS 19 37.6 ± 3.3 5.7 ± 3.3 16.9 ± 1.8
LIF 17 39.6 ± 4.1 9.1 ± 4.4c 16.8 ± 1.6
a
The non-injected eyes of the PBS-and LIF-injected animals were not significantly different from each other and were therefore combined for the analysis.
Each animal had one eye injected and the other non-injected; therefore, the weights of the non-injected eyes are analyzed with the injected pups data.
b
p < 0.045 t-test LIF-injected vs control.
c
p < 0.0001 ANOVA; significantly different from non-injected at p < 0.0001 and PBS-injected at p < 0.022, both Bonferroni correction.
d
Weights from a subset of nine animals within this group.
Exp Eye Res. Author manuscript; available in PMC 2007 March 15.
